TC
IDXX icon

Telemus Capital’s Idexx Laboratories IDXX Stock Holding History

Telemus Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-487
Closed -$266K – 362
2022
Q1 		$266K Buy
487
+37
+8% +$19.5K 0.02% 291
2021
Q4 		$296K Buy
450
+44
+11% +$27.6K 0.02% 301
2021
Q3 		$252K Sell
406
-27
-6% -$18.1K 0.02% 304
2021
Q2 		$273K Buy
+433
New +$239K 0.02% 297
2018
Q4 		– Sell
-6,090
Closed -$1.52M – 442
2018
Q3 		$1.52M Sell
6,090
-10
-0.2% -$2.43K 0.11% 145
2018
Q2 		$1.33M Hold
6,100
– – 0.1% 166
2018
Q1 		$1.17M Sell
6,100
-10
-0.2% -$1.85K 0.09% 181
2017
Q4 		$955K Buy
6,110
+110
+2% +$17.3K 0.07% 206
2017
Q3 		$933K Hold
6,000
– – 0.11% 142
2017
Q2 		$969K Buy
+6,000
New +$974K 0.1% 156

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Telemus Capital's IDXX Position: Q2 2022 in Review

Telemus Capital sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 487 shares — an estimated $266K sold.

Telemus Capital first reported a position in IDXX in Q2 2017 and held it in 10 quarters. The position peaked at $1.52M in Q3 2018. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Telemus Capital reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Telemus Capital sold 487 Idexx Laboratories shares in Q2 2022, an estimated $266K.
  • Telemus Capital first reported a position in Idexx Laboratories in Q2 2017 and held it in 10 quarters.
  • Telemus Capital's Idexx Laboratories position peaked at $1.52M in Q3 2018.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Telemus Capital's 13F filing for Q2 2022, filed 3 Aug 2022.